Latest Developments in Global Ultrasonic Dissection Products Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Ultrasonic Dissection Products Market

  • Healthcare
  • Apr 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In January 2025, Medtronic plc (Ireland) introduced its next-generation Sonicision Curved Jaw Ultrasonic Dissection System in the European market after receiving CE Mark approval. The system offers enhanced vessel sealing, precise energy delivery, and ergonomic improvements for greater control during laparoscopic and open procedures. It is optimized for both general and advanced surgical applications, including colorectal, gynecologic, and hepatobiliary surgeries
  • In October 2024, during the American College of Surgeons (ACS) Clinical Congress 2024, Ethicon (a Johnson & Johnson company, U.S.) unveiled its Harmonic HD Elite+ Shears, designed with adaptive tissue technology to enable more efficient cutting and coagulation in minimally invasive surgeries. The system reduces thermal spread while maintaining strong hemostasis for critical vessel sealing up to 5mm
  • In September 2024, Olympus Corporation (Japan) launched its SONICBEAT G2 Ultrasonic Surgical System at the 2024 European Society of Surgical Oncology (ESSO) Congress. The upgraded system delivers improved energy modulation, dual mode cutting/coagulation options, and extended durability for long procedures. The new design minimizes fatigue for surgeons during high-volume operations
  • In September 2024, Stryker Corporation (U.S.) announced the launch of its ProDissect Ultrasonic Energy Platform, designed for urological and general surgical procedures. The system integrates smart sensing technology that provides real-time feedback to reduce unintended tissue trauma and optimize dissection speed and precision. Full commercial rollout is planned for Q1 2025 in North America and select European markets